Health

Results: 7213-7224 of 8091

New Post Hoc Phase 3 Data Analysis Shows AJOVY® (fremanezumab) Reduced Migraine Attacks in Adults with Migraine and Co-morbid Obesity

LifeArc announces £5 million drug repurposing programme for motor neuron disease

ReNAgade Therapeutics Appoints Paul Perreault to Board of Directors

PR Newswire associated0

Dragonfly Therapeutics Initiates Phase 1/1b Study of its IL-2 Immunotherapy in Patients with Advanced Solid Tumors

PR Newswire associated0

Affidea expands its presence in Europe with acquisitions in Spain and Romania

Nitinotes Surgical in Full Swing: Impressive Board Appointment, Over 90 Patients Treated, 400+ Sutures Performed, and a $10.1M Series B Funding Round Closure

Curia Recognized on India Pharma Outlook’s 2023 List of Top 10 CDMO Companies in India

Evolution Optiks Successfully Completes Data Collection in Clinical Study of Neuro-Optical Testing Device

PR Newswire associated0

ClariMed Opens New Office in Cambridge, MA, Expanding its Reach in the Heart of America's Medical Hub

PR Newswire associated0

Merck Launches First Ever AI Solution to Integrate Drug Discovery and Synthesis

Takeda and The New York Academy of Sciences Announce 2024 Innovators in Science Award Winners

Hansa Biopharma plans restructuring to strengthen long-term competitiveness and advance key deliverables